Insulin sensitivity correlates with glycogen synthesis rate, but not with von Willebrand factor in type 2 diabetes

European Journal of Internal Medicine

Volumn 13, Issue 7, 2002, Pages 439-444

  Sambataro, Maria ^a   Maioli, Mario ^b   Tonolo, Giancarlo ^b   Stehouwer, Coen D A ^c   Van Hinsbergh, Victor W M ^c   Piarulli, Francesco ^d   Nosadini, Romano ^b,e   Pacini, Giovanni ^e  

^a City Hospital   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF PADOVA   (Italy)

^e CNR   (Italy)

Author keywords

Albuminuria; Glucose effectiveness; Glycogen synthesis rate; Insulin sensitivity; Insulin modified intravenous glucose tolerance test; Von Willebrand factor antigen

Indexed keywords

ALBUMIN; BIOCHEMICAL MARKER; GLUCOSE; GLYCOGEN; INSULIN; VON WILLEBRAND FACTOR;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CALCULATION; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM INJURY; FEMALE; FIBROBLAST CULTURE; GLYCOGEN SYNTHESIS; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN CLEARANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SKIN BIOPSY;

EID: 0036792089     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00133-4     Document Type: Article

References (32)

1. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M.A., Oleggini M., Graziadei L., et al. Insulin resistance in essential hypertension. N Engl J Med. 317:1987;350-357.
2. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
3. Nosadini R., Cipollina M.R., Solini A., Sambataro M., Morecutti A., Doria A., et al. Close relationship between microalbuminuria and insulin resistance in essential hypertension and non-insulin-dependent diabetes mellitus. J Am Soc Nephrol. 3:1992;S56-S63.
4. Nosadini R., Solini A., Velussi M., Muollo B., Frigato F., Sambataro M., et al. Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes. 43:1994;491-499.
5. Nielsen S., Schmitz O., Orskov H., Mogensen C.E. Similar insulin sensitivity in type 2 patients with normo- and microalbuminuria. Diabetes Care. 18:1995;834-842.
6. Forsblom C.M., Eriksson J.G., Ekstrand A.V., Teepo A.M., Taskinen M.R., Groop L. Insulin resistance and abnormal albumin excretion in type 2 first degree relatives of patients with type 2. Diabetologia. 38:1995;363-369.
7. Nosadini R., Manzato E., Solini A., Fioretto P., Brocco E., Zambon S., et al. Peripheral, rather than hepatic insulin resistance and atherogenic lipoprotein phenotype predict cardiovascular complication in type 2. Eur J Clin Invest. 24:1994;258-266.
8. Mykkanen L., Haffner S.M., Kuusisto J., Pyorala K., Laakso M. Microalbuminuria precedes the development of type 2. Diabetes. 43:1994;552-557.
9. Porta M., La Selva M., Molinatti P.A. vonWillebrand factor and endothelial abnormalities in diabetic microangiopathy. Diabetes Care. 14:1991;167-172.
10. Stehouwer C.D.A., Nauta J.J.P., Zeldenrust G.C., Hackeng W.H.L., Donker A.J.M., denOttolander G.J.H. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 340:1992;319-323.
11. Jensen T. Increased plasma level of von Willebrand factor in type I (insulin dependent) diabetic patients with incipient nephropathy. Br Med J. 298:1989;27-28.
12. Landis EM, Pappenheimer JR. Exchange of substances through capillary walls. In: Handbook of physiology; circulation. Sect. 2, vol. 2, pp. 961-1034. Washington: American Physiological Society; 1963.
13. Bundgaard M. Vesicular transport in capillary endothelium: does it occur? Fed Proc. 42:1983;2425-2430.
14. King G.L., Johnson S.M. Receptor-mediated transport of insulin across endothelial cells. Science. 227:1985;1583-1585.
15. 51Cr-EDTA provides a precise and convenient technique for measurement of glomerular filtration rate in diabetic humans. J Am Soc Nephrol. 7:1996;118-124.
16. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-2446.
17. Pacini G., Tonolo G., Sambataro M., Maioli M., Ciccarese M., Brocco E., et al. Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified IVGTT. Am J Physiol. 274:1998;E592-E599.
18. Solini A., Di Virgilio F., Trevisan M., Sfriso A., Crepaldi G., Nosadini R. Intracellular calcium handling by fibroblasts from non insulin dependent diabetic patients with and without hypertension and microalbuminuria. Kidney Int. 50:1997;618-626.
19. Lip G.Y.H., Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 34:1997;255-265.
20. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 32:1989;219-226.
21. Huszka M., Kaplar M., Rejto L., Tornai I., Palatka K., Laszlo P., et al. The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus. Thromb Res. 86:1997;173-180.
22. Lim S.C., Caballero A.E., Smakowski P., LoGerfo F.V., Horton E.S., Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care. 22:1999;1865-1870.
23. Steil G.M., Ader M., Moore D.M., Rebrin K., Bergman R.N. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process. J Clin Invest. 97:1996;1497-1503.
24. Brunner F., Wascher T.C. Contribution of the endothelium to transcapillary insulin transport in rat isolated perfused hearts. Diabetes. 47:1998;1127-1134.
25. Wascher T.C., Wölkart G., Russel J.C., Brunner F. Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats. Diabetes. 49:2000;803-809.
26. Bergman R.N. New concepts in extracellular signaling for insulin action: the single gateway hypothesis. Rec Prog Horm Res. 42:1997;359-385.
27. Podskalny J.M., Kahn C.R. Cell culture studies on patients with extreme insulin resistance. Abnormal biological responses in cultured fibroblasts. J Clin Endocrinol Metab. 54:1982;269-275.
28. 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 322:1990;223-228.
29. Schanlin-Jatti C., Harkonen M., Groop L. Impaired activation of glycogen synthase in people at increased risk for developing type 2. Diabetes. 41:1992;598-604.
30. Kelley D.E., Mintun M.A., Watkins S.C., Simoneau J.A., Jadali F., Fredrickson A., et al. The effect of non-insulin dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest. 97:1996;2705-2713.
31. Bonadonna R.C., Del Prato S., Saccomani M.P., Bonora E., Gulli G., Ferrannini E., et al. Transmembrane glucose transport in skeletal muscle of patients with non insulin dependent diabetes. J Clin Invest. 92:1993;486-494.
32. Damsgaard E.M., Froland A., Jorgensen O.D., Mogensen K.E. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J. 300:1990;297-300.